Letter

Important differences exist between second generation antidepressants

BMJ 1995; 311 doi: 10.1136/bmj.311.7007.751a (Published 16 September 1995)
Cite this as: BMJ 1995;311:751.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. John J Ferguson,
  2. Peter J Smith,
  3. Martin G V Jenkins
  1. Medical director Director, pharmaceutical advisory services Pharmaceutical division manager Prescription Pricing Authority, Newcastle upon Tyne NE1 6SN

    EDITOR,--I M Anderson and B M Tomenson discuss the relative tolerability of second generation antidepressants and state: “However, they are of minor importance clinically in terms of numbers of prescriptions and, with regard to cost effectiveness analyses, many …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular